Clovis Oncology, execs to pay $20 million to settle SEC charges
U.S. biotechnology company Clovis Oncology Inc and its Chief Executive Patrick Mahaffy and former CFO Erle Mast, will pay more than $20 million to settle charges of misleading investors about the efficacy of a cancer drug, the top U.S. securities regulator said on Tuesday.
from Reuters: Health News https://reut.rs/2OzS4nn
http://bit.ly/2zwRqiM